Health
COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows – Drug Target Review
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
Posted: 1 December 2020 | Victoria Rees (Drug Target Review) | No comments yet
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
A new COVID-19 vaccine candidate has shown success in mouse models by inducing high levels of antibodies against the S1 fragment of the SARS-CoV-2 Spike (S) protein.
Developed by BioVaxys Technology, the vaccine, called BVX-0320, did not produce any toxicity in the mice. According to the researchers,…
-
Business23 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News23 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General17 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General22 hours agoOlder Aussies back increased superannuation tax